blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2794651

EP2794651 - EXPRESSION VECTOR ELEMENT COMBINATIONS, NOVEL PRODUCTION CELL GENERATION METHODS AND THEIR USE FOR THE RECOMBINANT PRODUCTION OF POLYPEPTIDES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.07.2023
Database last updated on 29.03.2025
FormerThe patent has been granted
Status updated on  19.08.2022
FormerGrant of patent is intended
Status updated on  17.05.2022
FormerExamination is in progress
Status updated on  04.05.2017
FormerGrant of patent is intended
Status updated on  10.04.2017
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 09.10.2024  [2024/41]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[2022/38]
Former [2014/44]For all designated states
F.Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
Inventor(s)01 / HUELSMANN, Peter Michael
Im Sonnental 20
82392 Habach / DE
02 / KNOETGEN, Hendrik
Rebacker 26
79650 Schopfheim / DE
 [2017/23]
Former [2014/44]01 / HUELSMANN, Peter Michael
Im Sonnental 20
82392 Habach / DE
02 / KNOETGEN, Hendrik
Agathe-Fleissner-Weg 16
82377 Penzberg / DE
Representative(s)Burger, Alexander, et al
Roche Diagnostics GmbH
Patentabteilung
Nonnenwald 2
82377 Penzberg / DE
[2022/38]
Former [2014/44]Burger, Alexander, et al
Roche Diagnostics GmbH Patent Department (LPP.....6164) P.O.Box 11 52
82372 Penzberg / DE
Application number, filing date12810245.619.12.2012
[2022/38]
WO2012EP76203
Priority number, dateEP2011019536122.12.2011         Original published format: EP 11195361
[2014/44]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2013092743
Date:27.06.2013
Language:EN
[2013/26]
Type: A2 Application without search report 
No.:EP2794651
Date:29.10.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 27.06.2013 takes the place of the publication of the European patent application.
[2014/44]
Type: B1 Patent specification 
No.:EP2794651
Date:21.09.2022
Language:EN
[2022/38]
Search report(s)International search report - published on:EP03.10.2013
ClassificationIPC:C07K16/00, C12N15/67
[2014/44]
CPC:
C12N15/85 (EP,CN,KR,RU,US); C07K16/00 (EP,CN,KR,RU,US); C07K16/2854 (EP,CN,KR,RU,US);
C07K16/468 (CN,RU,US); C07K2317/14 (CN,US); C12N2830/00 (EP,CN,KR,US);
C12N2830/36 (EP,CN,KR,US); C12N2830/42 (EP,CN,KR,US); C12N2840/203 (EP,CN,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/44]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:EXPRESSIONSVEKTORELEMENTKOMBINATIONEN, NEUE VERFAHREN ZUR PRODUKTIONSZELLENERZEUGUNG UND DEREN VERWENDUNG BEI DER REKOMBINANTEN HERSTELLUNG VON POLYPEPTIDEN[2014/44]
English:EXPRESSION VECTOR ELEMENT COMBINATIONS, NOVEL PRODUCTION CELL GENERATION METHODS AND THEIR USE FOR THE RECOMBINANT PRODUCTION OF POLYPEPTIDES[2014/44]
French:COMBINAISONS D'ÉLÉMENTS DE VECTEUR D'EXPRESSION, NOUVEAUX PROCÉDÉS DE GÉNÉRATION DE CELLULES DE PRODUCTION ET LEUR UTILISATION POUR LA PRODUCTION RECOMBINANTE DE POLYPEPTIDES[2014/44]
Entry into regional phase22.07.2014National basic fee paid 
22.07.2014Designation fee(s) paid 
22.07.2014Examination fee paid 
Examination procedure26.05.2014Amendment by applicant (claims and/or description)
22.07.2014Examination requested  [2014/44]
10.06.2016Despatch of a communication from the examining division (Time limit: M04)
18.10.2016Reply to a communication from the examining division
11.04.2017Communication of intention to grant the patent
28.04.2017Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
20.02.2018Date of oral proceedings
05.03.2018Despatch of communication that the application is refused, reason: substantive examination {1}
05.03.2018Minutes of oral proceedings despatched
18.05.2022Communication of intention to grant the patent
12.08.2022Fee for grant paid
12.08.2022Fee for publishing/printing paid
12.08.2022Receipt of the translation of the claim(s)
Appeal following examination04.05.2018Appeal received No.  T1989/18
16.07.2018Statement of grounds filed
16.12.2021Result of appeal procedure: remittal for grant
21.12.2021Despatch of the decision of the Board of Appeal
Divisional application(s)EP18157484.9  / EP3354660
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  10.06.2016
Opposition(s)22.06.2023No opposition filed within time limit [2023/35]
Fees paidRenewal fee
05.12.2014Renewal fee patent year 03
07.12.2015Renewal fee patent year 04
08.12.2016Renewal fee patent year 05
08.12.2017Renewal fee patent year 06
10.12.2018Renewal fee patent year 07
10.12.2019Renewal fee patent year 08
09.12.2020Renewal fee patent year 09
16.12.2021Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU19.12.2012
AL21.09.2022
BG21.09.2022
CY21.09.2022
CZ21.09.2022
DK21.09.2022
EE21.09.2022
FI21.09.2022
LT21.09.2022
LV21.09.2022
MC21.09.2022
MK21.09.2022
MT21.09.2022
RS21.09.2022
SK21.09.2022
SM21.09.2022
LU19.12.2022
NO21.12.2022
IS21.01.2023
PT23.01.2023
[2024/41]
Former [2024/34]HU19.12.2012
AL21.09.2022
BG21.09.2022
CY21.09.2022
CZ21.09.2022
DK21.09.2022
EE21.09.2022
FI21.09.2022
LT21.09.2022
LV21.09.2022
MC21.09.2022
MK21.09.2022
RS21.09.2022
SK21.09.2022
SM21.09.2022
LU19.12.2022
NO21.12.2022
IS21.01.2023
PT23.01.2023
Former [2024/29]HU19.12.2012
AL21.09.2022
CY21.09.2022
CZ21.09.2022
DK21.09.2022
EE21.09.2022
FI21.09.2022
LT21.09.2022
LV21.09.2022
MC21.09.2022
MK21.09.2022
RS21.09.2022
SK21.09.2022
SM21.09.2022
LU19.12.2022
NO21.12.2022
IS21.01.2023
PT23.01.2023
Former [2024/27]HU19.12.2012
AL21.09.2022
CY21.09.2022
CZ21.09.2022
DK21.09.2022
EE21.09.2022
FI21.09.2022
LT21.09.2022
LV21.09.2022
MK21.09.2022
RS21.09.2022
SK21.09.2022
SM21.09.2022
LU19.12.2022
NO21.12.2022
IS21.01.2023
PT23.01.2023
Former [2024/21]HU19.12.2012
AL21.09.2022
CY21.09.2022
CZ21.09.2022
DK21.09.2022
EE21.09.2022
FI21.09.2022
LT21.09.2022
LV21.09.2022
RS21.09.2022
SK21.09.2022
SM21.09.2022
LU19.12.2022
NO21.12.2022
IS21.01.2023
PT23.01.2023
Former [2024/18]HU19.12.2012
AL21.09.2022
CZ21.09.2022
DK21.09.2022
EE21.09.2022
FI21.09.2022
LT21.09.2022
LV21.09.2022
RS21.09.2022
SK21.09.2022
SM21.09.2022
LU19.12.2022
NO21.12.2022
IS21.01.2023
PT23.01.2023
Former [2023/38]AL21.09.2022
CZ21.09.2022
DK21.09.2022
EE21.09.2022
FI21.09.2022
LT21.09.2022
LV21.09.2022
RS21.09.2022
SK21.09.2022
SM21.09.2022
LU19.12.2022
NO21.12.2022
IS21.01.2023
PT23.01.2023
Former [2023/34]AL21.09.2022
CZ21.09.2022
DK21.09.2022
EE21.09.2022
FI21.09.2022
LT21.09.2022
LV21.09.2022
RS21.09.2022
SK21.09.2022
SM21.09.2022
NO21.12.2022
IS21.01.2023
PT23.01.2023
Former [2023/29]AL21.09.2022
CZ21.09.2022
EE21.09.2022
FI21.09.2022
LT21.09.2022
LV21.09.2022
RS21.09.2022
SK21.09.2022
SM21.09.2022
NO21.12.2022
IS21.01.2023
PT23.01.2023
Former [2023/27]CZ21.09.2022
EE21.09.2022
FI21.09.2022
LT21.09.2022
LV21.09.2022
RS21.09.2022
SK21.09.2022
SM21.09.2022
NO21.12.2022
IS21.01.2023
PT23.01.2023
Former [2023/23]CZ21.09.2022
EE21.09.2022
FI21.09.2022
LT21.09.2022
LV21.09.2022
RS21.09.2022
SK21.09.2022
SM21.09.2022
NO21.12.2022
PT23.01.2023
Former [2023/22]CZ21.09.2022
FI21.09.2022
LT21.09.2022
LV21.09.2022
RS21.09.2022
SM21.09.2022
NO21.12.2022
PT23.01.2023
Former [2023/20]FI21.09.2022
LT21.09.2022
LV21.09.2022
RS21.09.2022
SM21.09.2022
NO21.12.2022
Former [2023/09]FI21.09.2022
LT21.09.2022
LV21.09.2022
RS21.09.2022
NO21.12.2022
Former [2023/08]FI21.09.2022
LT21.09.2022
RS21.09.2022
NO21.12.2022
Cited inInternational search[Y]WO2010097437  (UCB PHARMA SA [BE], et al) [Y] 82-84,87-91,100-108 * figure 3a *;
    [XDYI] - SANNA PIETRO P, "EXPRESSION OF ANTIBODY FAB FRAGMENTS AND WHOLE IMMUNOGLOBULIN IN MAMMALIAN CELLS", METHODS IN MOLECULAR BIOLOGY, HUMANA PRESS INC, NJ, US, (20020101), vol. 178, ISSN 1064-3745, pages 389 - 395, XP009083985 [XD] 82,89 * the whole document * [Y] 31-69,74,81-84,86-91,93,100-108 [I] 1-3,5-14,16-22,85
 [A]  - YEW N S ET AL, "OPTIMIZATION OF PLASMID VECTORS FOR HIGH-LEVEL EXPRESSION IN LUNG EPITHELIAL CELLS", HUMAN GENE THERAPY, MARY ANN LIEBERT, NEW YORK ,NY, US, (19970320), vol. 8, no. 5, ISSN 1043-0342, pages 575 - 584, XP000940966 [A] 23-30,80,92 * abstract * * page 577, column r, paragraph last * * page 578, column l, paragraph 1 * * figures 1-4 *
 [A]  - D. KIM ET AL, "Improved Mammalian Expression Systems by Manipulating Transcriptional Termination Regions", BIOTECHNOLOGY PROGRESS, (20031003), vol. 19, no. 5, doi:10.1021/bp0341186, ISSN 8756-7938, pages 1620 - 1622, XP055030207 [A] 23-30,80,92 * the whole document *

DOI:   http://dx.doi.org/10.1021/bp0341186
 [Y]  - WINNARD PAUL JR ET AL, "Robust expression of transgenes in MCF-7 breast cancer cells is expression vector-dependent", BIOTECHNIQUES, (200409), vol. 37, no. 3, ISSN 0736-6205, XP002699747 [Y] 31-69,74,81,86,93,100-108 * page 372, column l *
 [XYI]  - STEVEN C L HO ET AL, "IRES-mediated Tricistronic vectors for enhancing generation of high monoclonal antibody expressing CHO cell lines", JOURNAL OF BIOTECHNOLOGY, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 157, no. 1, doi:10.1016/J.JBIOTEC.2011.09.023, ISSN 0168-1656, (20110919), pages 130 - 139, (20111017), XP028395739 [X] 70,72,75-77,79,94-96 * page 131, column r, paragraph 1 * * figures 1(B), 1(C) * [Y] 97-108 [I] 71,78

DOI:   http://dx.doi.org/10.1016/j.jbiotec.2011.09.023
 [XY]  - LI ET AL, "A comparative study of different vector designs for the mammalian expression of recombinant IgG antibodies", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS B.V.,AMSTERDAM, NL, (20070103), vol. 318, no. 1-2, doi:10.1016/J.JIM.2006.10.010, ISSN 0022-1759, pages 113 - 124, XP005820142 [X] 94-96 * abstract * * figure 1A * [Y] 97-99

DOI:   http://dx.doi.org/10.1016/j.jim.2006.10.010
 [Y]  - JIN-CHING LEE ET AL, "High-efficiency protein expression mediated by enterovirus 71 internal ribosome entry", BIOTECHNOLOGY AND BIOENGINEERING, WILEY & SONS, HOBOKEN, NJ, US, vol. 90, no. 5, doi:10.1002/BIT.20440, ISSN 0006-3592, (20050605), pages 656 - 662, (20050407), XP002677796 [Y] 97-99 * figures 1, 3, 4 *

DOI:   http://dx.doi.org/10.1002/BIT.20440
 [Y]  - HOTTA A ET AL, "Production of anti-CD2 chimeric antibody by recombinant animal cells", JOURNAL OF BIOSCIENCE AND BIOENGINEERING, ELSEVIER, AMSTERDAM, NL, (20040101), vol. 98, no. 4, ISSN 1389-1723, pages 298 - 303, XP004649520 [Y] 97-99 * abstract * * figure 1 *
by applicantUS4676980
 EP0307434
 US4816567
 EP0404097
 US5122458
 US5168062
 WO9301161
 WO9308829
 US5225348
 WO9316185
 US5266491
 US5571894
 US5587458
 US5648237
 WO9730087
 US5731168
 US5750373
 US5770429
 US5789199
 US5821337
 US5840523
 WO9858964
 US5869046
 US5888809
 WO9922764
 US5959177
 US6040498
 US6075181
 WO0061739
 US6150584
 WO0129246
 US6248516
 WO0231140
 US6417429
 US6420548
 US2002164328
 WO03011878
 US2003115614
 US6602684
 US2003157108
 WO03085119
 WO03084570
 WO03085107
 US2004093621
 US2004110704
 US2004110282
 US2004109865
 US2004132140
 WO2004056312
 US2005079574
 WO2005035586
 WO2005035778
 US2005119455
 US2005123546
 WO2005053742
 WO2005100402
 US2005266000
 US6982321
 US2006025576
 US7041870
 US7053202
 US7087409
 US7125978
 US7189826
 US2007061900
 US2007117126
 US2007160598
 US2007237764
 US2007292936
 US2008069820
 WO2008077546
 US7422874
 WO2008142124
 US2009002360
 US7527791
 WO2009080251
 WO2009080252
 WO2009080253
 WO2009080254
 WO2009089004
 WO2010112193
 WO2010115589
 WO2010136172
 WO2010145792
 WO2010145793
    - METH. MOL. BIOL., (2002), vol. 178, pages 389 - 395
    - HIGUCHI, K. ET AL., J. IMMUNOL. METH., (1997), vol. 202, pages 193 - 204
    - BIOTECHNOL. PROGRESS, (2003), vol. 19, pages 1620 - 1622
    - COSTA, R.A. ET AL., EUR. J. PHARMACEUT. BIOPHARMACEUT., (2010), vol. 74, pages 127 - 138
    - GENE, (1990), vol. 91, pages 217 - 223
    - BUCHMAN, A.R. ET AL., MOL. CELL. BIOL., (1988), vol. 8, pages 4395 - 4405
    - WANG, F. ET AL., Therapeutic monoclonal antibodies - From bench to clinic, WILEY, (2009), pages 557 - 572
    - LI ET AL., J. IMMUNOL., (2007), vol. 318, pages 113 - 124
    - J. BIOTECHNOL., (2011), vol. 157, pages 130 - 139
    - HOTTA, A. ET AL., J. BIOSCI. BIOENG., (2004), vol. 98, pages 298 - 303
    - BIOTECHNOL. BIOENG., (2005), vol. 90, pages 656 - 662
    - SHIELDS, R.L. ET AL., J. BIOL. CHEM., (2001), vol. 276, pages 6591 - 6604
    - LUND, J. ET AL., FASEB J., (1995), vol. 9, pages 115 - 119
    - MORGAN, A. ET AL., IMMUNOLOGY, (1995), vol. 86, pages 319 - 324
    - CHOTHIA, C.; LESK, A.M., J. MOL. BIOL., (1987), vol. 196, pages 901 - 917
    - ALMAGRO, J.C.; FRANSSON, J., FRONT. BIOSCI., (2008), vol. 13, pages 1619 - 1633
    - PELLETIER, J. ET AL., NATURE, (1988), vol. 334, pages 320 - 325
    - JANG, S.K. ET AL., J. VIROL., (1989), vol. 63, pages 1651 - 1660
    - DAVIES, M.V. ET AL., J. VIROL., (1992), vol. 66, pages 1924 - 1932
    - ADAM, M.A. ET AL., J. VIROL., (1991), vol. 65, pages 4985 - 4990
    - MORGAN, R.A. ET AL., NUCL. ACIDS RES., (1992), vol. 20, pages 1293 - 1299
    - SUGIMOTO, Y ET AL., BIOTECHNOLOGY, (1994), vol. 12, pages 694 - 698
    - RAMESH, N. ET AL., NUCL. ACIDS RES., (1996), vol. 24, pages 2697 - 2700
    - MOSSER, D.D. ET AL., BIOTECHNIQUES, (1997), vol. 22, pages 150 - 152
    - MCGEHEE, R.E. ET AL., MOL. ENDOCRINOL., (1993), vol. 7, page 551
    - TREISMAN, R., SEMINARS IN CANCER BIOL., (1990), vol. 1, page 47
    - O'REILLY, M.A. ET AL., J. BIOL. CHEM., (1992), vol. 267, page 19938
    - YE, J. ET AL., J. BIOL. CHEM., (1994), vol. 269, page 25728
    - LOEKEN, M.R., GENE EXPR., (1993), vol. 3, page 253
    - LEMAIGRE, F.P.; ROUSSEAU, G.G., BIOCHEM. J., (1994), vol. 303, pages 1 - 14
    - GOSSEN, M.; BUJARD, H., PNAS, (1992), vol. 89, pages 5547 - 5551
    - GOSSEN ET AL., CURR. OPIN. BIOTECH., (1994), vol. 5, pages 516 - 520
    - SINGER, 0., PROC. NATL. ACAD. SCI. USA, (2004), vol. 101, pages 5313 - 5314
    - KINDT, T.J. ET AL., Kuby Immunology, W.H. FREEMAN AND CO., (2007), page 91
    - PORTOLANO, S. ET AL., J. IMMUNOL., (1993), vol. 150, pages 880 - 887
    - CLACKSON, T. ET AL., NATURE, (1991), vol. 352, pages 624 - 628
    - HUDSON, P.J. ET AL., NAT. MED., (2003), vol. 9, pages 129 - 134
    - PLUECKTHUN, A., The Pharmacology of Monoclonal Antibodies, SPRINGER-VERLAG, (1994), vol. 113, pages 269 - 315
    - HOLLIGER, P. ET AL., PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, pages 6444 - 6448
    - MORRISON, S.L. ET AL., PROC. NATL. ACAD. SCI. USA, (1984), vol. 81, pages 6851 - 6855
    - RIECHMANN, I. ET AL., NATURE, (1988), vol. 332, pages 323 - 329
    - QUEEN, C. ET AL., PROC. NATL. ACAD. SCI. USA, (1989), vol. 86, pages 10029 - 10033
    - KASHMIRI, S.V. ET AL., METHODS, (2005), vol. 36, pages 25 - 34
    - PADLAN, E.A., MOL. IMMUNOL., (1991), vol. 28, pages 489 - 498
    - DALL'ACQUA, W.F. ET AL., METHODS, (2005), vol. 36, pages 43 - 60
    - OSBOURN, J. ET AL., METHODS, (2005), vol. 36, pages 61 - 68
    - KLIMKA, A. ET AL., BR. J. CANCER, (2000), vol. 83, pages 252 - 260
    - SIMS, M.J. ET AL., J. IMMUNOL., (1993), vol. 151, pages 2296 - 2308
    - CARTER, P. ET AL., PROC. NATL. ACAD. SCI. USA, (1992), vol. 89, pages 4285 - 4289
    - PRESTA, L.G. ET AL., J. IMMUNOL., (1993), vol. 151, pages 2623 - 2632
    - BACA, M. ET AL., J. BIOL. CHEM., (1997), vol. 272, pages 10678 - 10684
    - ROSOK, M.J. ET AL., J. BIOL. CHEM., (1996), vol. 271, pages 22611 - 22618
    - VAN DIJK, M.A.; VAN DE WINKEL, J.G., CURR. OPIN. PHARMACOL., (2001), vol. 5, pages 368 - 374
    - LONBERG, N., CURR. OPIN. IMMUNOL., (2008), vol. 20, pages 450 - 459
    - LONBERG, N., NAT. BIOTECH., (2005), vol. 23, pages 1117 - 1125
    - KOZBOR, D., J. IMMUNOL., (1984), vol. 133, pages 3001 - 3005
    - BRODEUR, B.R. ET AL., Monoclonal Antibody Production Techniques and Applications, MARCEL DEKKER, INC., (1987), pages 51 - 63
    - BOERNER, P. ET AL., J. IMMUNOL., (1991), vol. 147, pages 86 - 95
    - LI, J. ET AL., PROC. NATL. ACAD. SCI. USA, (2006), vol. 103, pages 3557 - 3562
    - NI, J., XIANDAI MIANYIXUE, (2006), vol. 26, pages 265 - 268
    - VOLLMERS, H.P.; BRANDLEIN, S., HISTOLOGY AND HISTOPATHOLOGY, (2005), vol. 20, pages 927 - 937
    - VOLLMERS, H.P.; BRANDLEIN, S., METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, (2005), vol. 27, pages 185 - 191
    - HOOGENBOOM, H.R. ET AL., METHODS IN MOLECULAR BIOLOGY, (2001), vol. 178, pages 1 - 37
    - MCCAFFERTY, J. ET AL., NATURE, (1990), vol. 348, pages 552 - 554
    - MARKS, J.D. ET AL., J. MOL. BIOL., (1992), vol. 222, pages 581 - 597
    - MARKS, J.D.; BRADBURY, A., METHODS IN MOLECULAR BIOLOGY, (2003), vol. 248, pages 161 - 175
    - SIDHU, S.S. ET AL., J. MOL. BIOL., (2004), vol. 338, pages 299 - 310
    - LEE, C.V. ET AL., J. MOL. BIOL., (2004), vol. 340, pages 1073 - 1093
    - FELLOUSE, F.A., PROC. NATL. ACAD. SCI. USA, (2004), vol. 101, pages 12467 - 12472
    - LEE, C.V. ET AL., J. IMMUNOL. METHODS, (2004), vol. 284, pages 119 - 132
    - WINTER, G. ET AL., ANN. REV. IMMUNOL., (1994), vol. 12, pages 433 - 455
    - GRIFFITHS, A.D. ET AL., EMBO J., (1993), vol. 12, pages 725 - 734
    - HOOGENBOOM, H.R.; WINTER, G., J. MOL. BIOL., (1992), vol. 227, pages 381 - 388
    - MILSTEIN, C.; CUELLO, A.C., NATURE, (1983), vol. 305, pages 537 - 540
    - TRAUNECKER, A. ET AL., EMBO J., (1991), vol. 10, pages 3655 - 3659
    - BRENNAN, M. ET AL., SCIENCE, (1985), vol. 229, pages 81 - 83
    - KOSTELNY, S.A. ET AL., J. IMMUNOL., (1992), vol. 148, pages 1547 - 1553
    - GRUBER, M. ET AL., J. IMMUNOL., (1994), vol. 152, pages 5368 - 5374
    - TUTT, A. ET AL., J. IMMUNOL., (1991), vol. 147, pages 60 - 69
    - WRIGHT, A.; MORRISON, S.L., TIBTECH, (1997), vol. 15, pages 26 - 32
    - OKAZAKI, A. ET AL., J. MOL. BIOL., (2004), vol. 336, pages 1239 - 1249
    - YAMANE-OHNUKI, N. ET AL., BIOTECH. BIOENG., (2004), vol. 87, pages 614 - 622
    - RIPKA, J. ET AL., ARCH. BIOCHEM. BIOPHYS., (1986), vol. 249, pages 533 - 545
    - KANDA, Y. ET AL., BIOTECHNOL. BIOENG., (2006), vol. 94, pages 680 - 688
    - CHARLTON, K.A., Methods in Molecular Biology, HUMANA PRESS, (2003), vol. 248, pages 245 - 254
    - GERNGROSS, T.U., NAT. BIOTECH., (2004), vol. 22, pages 1409 - 1414
    - LI, H. ET AL., NAT. BIOTECH., (2006), vol. 24, pages 210 - 215
    - GRAHAM, F.L. ET AL., J. GEN VIROL., (1977), vol. 36, pages 59 - 74
    - MATHER, J.P., BIOL. REPROD., (1980), vol. 23, pages 243 - 252
    - MATHER, J.P ET AL., ANNALS N.Y. ACAD. SCI., (1982), vol. 383, pages 44 - 68
    - URLAUB, G. ET AL., PROC. NATL. ACAD. SCI. USA, (1980), vol. 77, pages 4216 - 4220
    - YAZAKI, P.; WU, A.M., Methods in Molecular Biology, HUMANA PRESS, (2004), vol. 248, pages 255 - 268
    - XU ET AL., J. CONTROL. RELEASE, (2002), vol. 81, pages 155 - 163
    - XIA ET AL., PROT. EXPR. PURIF., (2006), vol. 45, pages 115 - 124
    - TESCHENDORF ET AL., ANTICANCER RES., (2002), vol. 22, pages 3325 - 3330
    - LI ET AL., J. IMMUNOL. METHODS, (2007), vol. 318, pages 113 - 124
    - ARTELT ET AL., GENE, (1988), vol. 68, pages 213 - 219
    - STOCKING ET AL., PROC. NATL. ACAD. SCI. USA, (1985), vol. 82, pages 5746 - 5750
    - LIN ET AL., GENE, (1994), vol. 147, pages 287 - 292
    - LIU ET AL., ANAL. BIOCHEM., (1996), vol. 246, pages 150 - 152
    - KOMURO ET AL., EMBO J., (1993), vol. 12, pages 1387 - 1401
    - MOUNTFORD ET AL., PROC. NATL. ACAD. SCI. USA, (1991), vol. 91, pages 4303 - 4307
    - LEE ET AL., BIOTECHNOL. BIOENG., (2005), vol. 90, pages 656 - 662
    - WONG ET AL., GENE THER., (2002), vol. 9, pages 337 - 344
    - CHAPPELL ET AL., PROC. NATL. ACAD. SCI. USA, (2000), vol. 97, pages 1536 - 1541
    - PICARD, D.; SCHAFFNER, W., NATURE, (1984), vol. 307, pages 80 - 82
    - NEUBERGER, M.S., EMBO J., (1983), vol. 2, pages 1373 - 1378
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.